Sun Pharma Share Price Bse India

Their registrars are acc ltd. Market share gains for major specialty. The consensus estimate represents an upside of 0.77% from the last price of 569.05.

lincoln tech college indianapolis lincoln tech nj canvas la tech football score la tech football score 2020 kentucky vs georgia tech basketball lake area tech admissions lincoln tech nashville number la tech vs lsu engineering

Sensex ends 145 pts down, Nifty at 7,786 Stock market

A meeting of the Board of Directors of Sun Pharma Advanced

In intraday trading is it compulsory to buy and sell the

Navy Day Navy day, Naval force, Navy

Nifty Market Expert The Fall In Sensex, Shares Of ITC And

EthicalResearch thought thoughtoftheday TOTD quote

Sun pharma share price has zoomed 5% and is presently trading at rs 538.

Sun pharma share price bse india. The pharma firm stock, however. For the year ending march 2020 sun pharmaceutical industries has declared an equity dividend of 400.00% amounting to rs 4 per share. Shares of gland pharma opened at rs 2,111.20 today against the closing price of rs 2091.85 and later hit an intraday high of rs 2178, logging a gain of 4.12% on bse.

Share price forecast the 47 reports from 13 analysts offering long term price targets for sun pharmaceutical industries ltd. Have an average target of 573.42. At the current share price of rs 511.65 this results in a.

Get the list of top pharmaceuticals & drugs companies in india (bse) based on market capitalization Share today 3.79% up, find live bse/ nse stock price of sun pharmaceutical industries ltd. It has surged 11 per cent in the past four trading days on the bse

Sun pharma was in focus on tuesday after reports said that the promoter shanghvi finance pledged 10 lakh shares in favour of deutsche investments india. Nse, bse share price messages, comments on sun pharma inds. With view of historical charts, stock market reports, financial report.

With india’s leading brokerage platform with groww.in. Find market predictions, sunpharma financials and market news. Motilal oswal financial services has buy call on sun pharmaceutical industries with a target price of rs 600.

Retain ‘buy’ on stock, raise tp to rs 620 from rs 605 november 5, 2020 12:30 am retain ‘buy’; The brokerage firm maintains ‘buy’ rating on laurus labs with target price of rs 410 per share. A couple of events, namely sun pharma getting the approval by the competition commission of india (cci) to sell formerly ranbaxy laboratories’ cns segment in india to strides, and the anticipation of q3 results for fy16 took the stock price to rs.836.80.